iovera° appreciates being able to connect with patients and health care providers. This helps us learn how we can support them. We hope to see you in your community soon.

Check out where we’ve been making news below. To see where we’re going, follow us on LinkedIn!

November 2022, Phoenix, AZ CHARLES SCHWAB Event

The iovera° team joined the PGA TOUR Champions during the Charles Schwab Cup Championship in Phoenix recently. The team, located in the on-course iovera° Cool Zone tent, had the opportunity to educate volunteers and speak with spectators about non-opioid options like iovera°. One of the TOUR players, Paul Goydos, even sported iovera° swag on the course!

June 2022, Madison, WI AmFam Championship

Thank you, PGA TOUR Champions for having us at the AmFam Championship at University Ridge Golf Course. We had meaningful and impactful conversations with spectators and volunteers about non-opioid options like iovera°.

May 2022, Fort Lauderdale, FL National Senior Games

Pacira BioSciences, Inc. and the National Senior Games Association (NSGA) secured the new GUINNESS WORLD RECORDS title for the Largest Game of Freeze Dance. A total of 1,308 individuals participated in the record-breaking game during the 2022 National Senior Games.

April 2022, Irving, TX ClubCorp Classic

Our team had a blast at the 2022 PGA TOUR Champions ClubCorp Classic! We loved educating guests and volunteers about iovera° and how it can help patients.

Ready to talk with a doctor about iovera°?

See how people feel after iovera° treatment

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue.

Important Safety Information

The iovera° system should not be used in people with the following conditions:

  • Blood that thickens when patient is exposed to cold (cryoglobulinemia), blood appearing in the urine when patient is exposed to the cold (paroxysmal cold hemoglobinuria), skin rash that appears when patient is exposed to the cold (cold urticaria), narrowing of the blood vessels in the hands and feet when patient is exposed to the cold (Raynaud’s disease), and open and/or infected wounds at or near the treatment site

Patients being treated with the iovera° system (a needle-based therapy) may experience certain reactions, including, but not limited to:

  • Bruising, swelling, inflammation and/or redness, local pain and/or tenderness, and altered feeling at the site of application

Proper use of the device as described in the User Guide can help reduce or prevent the following complications:

  • In the area(s) where you were treated: damage to the skin from being exposed to cold or heat, darkening or lightening of the skin, and dimples in the skin
  • Outside the area(s) where you were treated: muscles may not work or move normally
More +

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain.

Important Safety Information